Case Details
- Citation: [2022] SGHC 234
- Title: Medica Singapore Pte Ltd v Chabtini Elias Georges
- Court: High Court of the Republic of Singapore (General Division)
- Suit No: Suit No 56 of 2021
- Date of Decision: 28 September 2022
- Judge: Valerie Thean J
- Hearing Dates: 4–7 April, 9 May 2022, 18 July 2022
- Plaintiff/Applicant: Medica Singapore Pte Ltd (“Medica SG”)
- Defendant/Respondent: Chabtini Elias Georges (“Mr Chabtini”)
- Shareholding/Directorship Context: Mr Chabtini held 48% of Medica SG’s shares and was formerly a director; Ms Virginia Seow held 52% and was the sole director at the time of the dispute
- Legal Area: Trusts — Express trusts (certainties; intention to create trust)
- Core Dispute: Whether trade marks registered in Medica SG’s name were held on express trust for another entity (SRS International S.P.R.L (“SRSI”)) such that Mr Chabtini could transfer them to EMA Aesthetics Limited (“EMA”)
- Statutes Referenced: Not specified in the provided extract
- Cases Cited: Guy Neale and others v Nine Squares Pty Ltd [2015] 1 SLR 1097 (cited for express trust principles)
- Judgment Length: 23 pages, 6,192 words
Summary
In Medica Singapore Pte Ltd v Chabtini Elias Georges, the High Court was asked to determine whether trade marks registered in the plaintiff company’s name were held on an express trust for a third party. The plaintiff, Medica SG, sued its former director, Mr Chabtini, after he arranged for the ownership of certain Singapore trade marks to be transferred to an Irish company, EMA, in circumstances where Medica SG protested that the transfers were unauthorised.
The central question was narrow but legally significant: whether an express trust existed over the trade marks in favour of SRS International S.P.R.L (“SRSI”). The defendant’s case was that the marks were always intended to belong beneficially to SRSI, and that Medica SG merely held the marks as a nominee because of practical difficulties in registering them in SRSI’s name at the time. If that contention were accepted, Mr Chabtini argued that his transfer to EMA was consistent with the beneficial ownership structure and did not breach fiduciary duties.
The court rejected the defendant’s trust argument. Applying the orthodox “three certainties” framework for express trusts—certainty of intention, certainty of subject matter, and certainty of objects—the judge found that the evidence did not establish the requisite intention to create a trust. As a result, Medica SG was entitled to declarations and orders requiring Mr Chabtini to take steps to reverse the wrongful transfers that remained outstanding, together with damages for the costs incurred in recovering the marks.
What Were the Facts of This Case?
Medica SG is a Singapore-incorporated company within the Medica Group. The group was originally founded in the United Arab Emirates by Mr Chabtini and Ms Tania Akl in the late 1990s or early 2000s. Medica SG was incorporated in 2002 as part of an international expansion plan. Its business included wholesale medical equipment for aesthetic and plastic surgery, as well as wholesale cosmetic and toiletry products.
At incorporation, the initial shareholders of Medica SG were Mr Chabtini and Mr Namir Robert Akl (Ms Akl’s husband). Mr Chabtini held 60% and Mr Akl held 40%. Later, Mr Akl transferred his shares to Ms Akl. Over time, Ms Virginia Seow became involved with the company and was eventually appointed director in 2015, replacing Ms Akl. When the dispute arose, Mr Chabtini and Ms Seow were the only directors. Ms Seow held 52% of the shares and was the sole director at the time of the litigation, while Mr Chabtini held 48%.
The dispute concerned two trade marks registered in Singapore in Medica SG’s name. The first was the “SRS Mark”, registered on 9 June 2006, renewed on 18 December 2015, and registered until June 2026 in class 3 for cosmetic and skin-related products. The second was a “Second Mark”, registered on 30 November 2015, also in class 3, with a different design but similar branding elements. Together, the marks were used for products associated with a line called “Skin Rejuvenation Solution”, abbreviated as “SRS”.
In early 2019, EMA was incorporated in Ireland to merge various brands, including SRSI, but not including Medica SG. Mr Chabtini was one of EMA’s directors. In June 2020, Mr Chabtini applied to IPOS to register transfers of the Second Mark to EMA in Singapore, and also transferred the SRS Mark registered in several other jurisdictions (including Hong Kong, Indonesia, Thailand, and Taiwan) to EMA. IPOS sought confirmation from Medica SG regarding the transfer request. Ms Seow emailed IPOS to state the transfer was unauthorised. Shortly thereafter, Mr Chabtini emailed IPOS asserting he was the owner and director of Medica SG and instructing IPOS to authorise the transfer.
Medica SG later discovered that registration transfers had been effected in multiple jurisdictions. It was able to reverse some of those transfers, but not all. In parallel, Medica SG removed Mr Chabtini as director at an extraordinary general meeting on 19 October 2020, and he resigned five days later. Medica SG commenced suit on 15 January 2021 seeking declarations of ownership, orders to transfer back remaining marks, and damages for wrongful transfer and related losses. By the time of trial, certain prayers were abandoned or withdrawn, and the remaining relief focused on damages for costs incurred in reversing transfers and an order requiring Mr Chabtini to take steps to transfer the SRS Mark in Indonesia and Taiwan back to Medica SG.
What Were the Key Legal Issues?
The sole issue for determination was whether the SRS Mark was held by Medica SG on an express trust for SRSI. This issue mattered because it went directly to the defendant’s fiduciary and ownership-based justification. If Medica SG held the marks on trust for SRSI, then beneficial ownership would lie with SRSI, and Mr Chabtini’s transfer to EMA could be characterised as dealing with property that he believed (and allegedly had authority to deal with) as part of the group’s restructuring.
Conversely, if no express trust existed, the marks remained beneficially owned by Medica SG as the registered proprietor, and Mr Chabtini’s actions as a director would likely constitute a breach of fiduciary duties. The court therefore had to focus not on whether Mr Chabtini subjectively intended that SRSI should benefit, but on whether the legal requirements for an express trust were satisfied—particularly the certainty of intention.
The court also had to consider the evidential and procedural context. Mr Chabtini’s defence relied on an alleged understanding that the marks were to be registered in Medica SG’s name “instead” due to challenges registering them in SRSI’s name at the time. However, neither SRSI nor EMA were joined as parties. This meant the court’s analysis had to proceed on the evidence available, without the benefit of direct participation by the alleged beneficial owner or transferee.
How Did the Court Analyse the Issues?
The judge began by restating the governing principles for express trusts. The parties did not dispute the legal framework. In Guy Neale and others v Nine Squares Pty Ltd, the Court of Appeal held that an express trust is created by the actual intention of the settlor, expressed by the settlor’s use of the word “trust” in a relevant instrument or inferred from the settlor’s words or conduct. The court emphasised that three certainties must be present: certainty of intention, certainty of subject matter, and certainty of objects.
Although the extract provided does not include the full reasoning, the court’s approach is clear from the way the issue was framed and from the emphasis on intention. The defendant’s case was that the “Skin Rejuvenation Solution” brand and trade mark were created by Mr Chabtini and his team in the 2000s, and that there were difficulties registering the SRS Mark in SRSI’s name when it was registered in 2006. The defendant asserted that it was “understood and agreed” between him and Ms Akl that the mark would be registered in Medica SG’s name and held on behalf of SRSI.
In analysing certainty of intention, the court would have looked for objective manifestations of a trust arrangement, such as documentation, contemporaneous communications, or conduct consistent with a trust rather than a corporate or contractual arrangement. The judge’s task was not to decide whether it would have been commercially sensible for SRSI to be beneficial owner, but whether the legal threshold for an express trust was met. Express trusts require more than a general expectation or belief that another party should benefit; they require a sufficiently certain intention to create enforceable trust obligations.
The court also had to grapple with the fact that the marks were registered in Medica SG’s name and that Medica SG was the registered proprietor. In trust disputes involving registered assets, the existence of a trust is not presumed merely because the parties are related or because there is an internal understanding. The court would therefore have required clear evidence that Medica SG was intended to hold the marks not for itself, but as trustee for SRSI. The defendant’s reliance on an “understood and agreed” arrangement, without the joining of SRSI and without the production of trust instruments or clear documentary evidence, would likely have weakened the argument on certainty of intention.
Further, the court’s reasoning would have been informed by the fiduciary context. Mr Chabtini was a director of Medica SG. Directors owe fiduciary duties to the company, including duties relating to proper use of corporate property and avoidance of unauthorised transfers. If Mr Chabtini’s actions were inconsistent with the company’s interests and were undertaken without proper authority, the court would be cautious about accepting a trust narrative that effectively recharacterises corporate assets as belonging beneficially to another entity, absent strong proof.
Finally, the court’s analysis would have addressed the practical consequences of the trust finding. If the court accepted that an express trust existed, it would have to reconcile that with the defendant’s conduct in dealing with IPOS and the company’s protest. If the court rejected the trust, the transfers would remain wrongful as dealings with property beneficially owned by Medica SG. The court’s ultimate conclusion—that the trust was not established—therefore resolved the fiduciary breach and ownership questions in Medica SG’s favour.
What Was the Outcome?
The court granted Medica SG the remedies it sought that remained live at trial. Specifically, it ordered Mr Chabtini to take steps to transfer the SRS Mark in Indonesia and Taiwan back to Medica SG. The court also awarded damages of $5,850.90, representing the costs incurred by Medica SG in reversing the transfers it was able to reverse.
Interest was awarded at 5.33% from the date of the writ. Mr Chabtini appealed, but the present judgment sets out the High Court’s reasoning and the legal basis for the orders made on 9 May 2022, with the written grounds delivered on 28 September 2022.
Why Does This Case Matter?
This decision is a useful reminder that express trusts are not created by implication from broad commercial narratives or family/group arrangements. Even where parties are closely connected and there is a plausible commercial reason for one entity to be beneficial owner, the court will require clear evidence of certainty of intention. The case reinforces that the “three certainties” framework is not a mere formality; it is a substantive evidential and legal threshold.
For practitioners, the case highlights the importance of documenting trust arrangements when corporate assets are intended to be held for another party. If a party wishes to rely on a trust to justify dealing with property, it should ensure that the trust intention is objectively manifested—through instruments, written agreements, or other reliable evidence—so that the court can confidently infer the settlor’s intention to create enforceable trust obligations.
The decision also has fiduciary implications for directors. Where directors deal with company assets, courts will scrutinise the basis for authority and the legal characterisation of ownership. A trust defence may fail if it is not established to the required standard, exposing directors to liability for breach of fiduciary duties and related damages.
Legislation Referenced
- Not specified in the provided extract.
Cases Cited
- Guy Neale and others v Nine Squares Pty Ltd [2015] 1 SLR 1097
Source Documents
This article analyses [2022] SGHC 234 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.